These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37562913)

  • 1. Correlating clinical breakpoint concentration of moxifloxacin with gyrA mutations using the GenoType MTBDRsl assay Version 2.0.
    Sidiq Z; Hanif M; Dwivedi KK; Chopra KK; Khanna A; Vashishat BK
    Indian J Tuberc; 2023 Jul; 70(3):361-365. PubMed ID: 37562913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.
    Singh K; Kumari R; Gupta S; Tripathi R; Srivastava A; Shakya V; Gupta A; Anupurba S
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):56. PubMed ID: 34446022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype MTBDRsl version 2 and phenotypic drug resistance detection of
    Radhakrishnan R; Prabuseenivasan S; Hannah S; Vaishanavee V; Senthildevi V; Kannadhasan T; Suchithra R; Rajendran P; Chinnaiyan P; Jayabal L; Frederick A; Shanmugam S
    Int J Mycobacteriol; 2023; 12(3):299-304. PubMed ID: 37721236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of Specific
    Singh PK; Singh U; Jain A
    Microb Drug Resist; 2021 May; 27(5):647-651. PubMed ID: 32991238
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic utility of GenoType MTBDR
    Yadav RN; Bhalla M; Kumar G; Sah GC; Dewan RK; Singhal R
    Int J Mycobacteriol; 2022; 11(2):183-189. PubMed ID: 35775551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan.
    Huang HT; Lin WH; Chan TH; Jou R
    J Microbiol Immunol Infect; 2023 Dec; 56(6):1236-1244. PubMed ID: 37690869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New generation fluoroquinolone sitafloxacin could potentially overcome the majority levofloxacin and moxifloxacin resistance in multidrug-resistant
    Sun Q; Cheng K; Liao X; Zhao W; Wang C; Wang C; Yan J; Dong L; Wang F; Jiang G; Huang H; Guo Z; Wang G
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 39028256
    [No Abstract]   [Full Text] [Related]  

  • 9. Pattern and characteristics of mutations conferring resistance to second line drugs in Mycobacterium tuberculosis isolates of pulmonary and extrapulmonary TB samples.
    Dixit R; Mohan E; Gupta A; Patni T
    Indian J Tuberc; 2024; 71 Suppl 1():S37-S43. PubMed ID: 39067953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
    Vīksna A; Sadovska D; Berge I; Bogdanova I; Vaivode A; Freimane L; Norvaiša I; Ozere I; Ranka R
    BMC Infect Dis; 2023 Sep; 23(1):638. PubMed ID: 37770850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients.
    Kabir S; Tahir Z; Mukhtar N; Sohail M; Saqalein M; Rehman A
    BMC Pulm Med; 2020 May; 20(1):138. PubMed ID: 32393213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Chien JY; Chiu WY; Chien ST; Chiang CJ; Yu CJ; Hsueh PR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2090-6. PubMed ID: 26787695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Sci Rep; 2021 Apr; 11(1):7765. PubMed ID: 33833390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MTBDR
    Chandak RJ; Malhotra B; Bhargava S; Goel SK; Verma D; Tiwari J
    Int J Tuberc Lung Dis; 2019 Dec; 23(12):1257-1262. PubMed ID: 31931908
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the GenoType MTBDR
    Gardee Y; Dreyer AW; Koornhof HJ; Omar SV; da Silva P; Bhyat Z; Ismail NA
    J Clin Microbiol; 2017 Mar; 55(3):791-800. PubMed ID: 27974543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
    Sayadi M; Zare H; Jamedar SA; Hashemy SI; Meshkat Z; Soleimanpour S; Hoffner S; Ghazvini K
    BMC Infect Dis; 2020 Jun; 20(1):390. PubMed ID: 32487030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
    Kambli P; Ajbani K; Sadani M; Nikam C; Shetty A; Udwadia Z; Rodwell TC; Catanzaro A; Rodrigues C
    Tuberculosis (Edinb); 2015 Mar; 95(2):137-41. PubMed ID: 25522842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
    Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
    J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco.
    Chaoui I; Oudghiri A; El Mzibri M
    J Glob Antimicrob Resist; 2018 Mar; 12():171-174. PubMed ID: 29033301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.